Copyright Reports & Markets. All rights reserved.

Global RNA Drugs Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 RNA Drugs Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China RNA Drugs Market Performance
    • 2.3 USA RNA Drugs Market Performance
    • 2.4 Europe RNA Drugs Market Performance
    • 2.5 Japan RNA Drugs Market Performance
    • 2.6 Korea RNA Drugs Market Performance
    • 2.7 India RNA Drugs Market Performance
    • 2.8 Southeast Asia RNA Drugs Market Performance
    • 2.9 South America RNA Drugs Market Performance

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China RNA Drugs Market Performance (Volume)
    • 3.3 USA RNA Drugs Market Performance (Volume)
    • 3.4 Europe RNA Drugs Market Performance (Volume)
    • 3.5 Japan RNA Drugs Market Performance (Volume)
    • 3.6 Korea RNA Drugs Market Performance (Volume)
    • 3.7 India RNA Drugs Market Performance (Volume)
    • 3.8 Southeast Asia RNA Drugs Market Performance (Volume)
    • 3.9 South America RNA Drugs Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Pfizer
      • 4.1.1 Pfizer Profiles
      • 4.1.2 Pfizer Product Information
      • 4.1.3 Pfizer RNA Drugs Business Performance
      • 4.1.4 Pfizer RNA Drugs Business Development and Market Status
    • 4.2 Roche
      • 4.2.1 Roche Profiles
      • 4.2.2 Roche Product Information
      • 4.2.3 Roche RNA Drugs Business Performance
      • 4.2.4 Roche RNA Drugs Business Development and Market Status
    • 4.3 Sanofi-Aventis
      • 4.3.1 Sanofi-Aventis Profiles
      • 4.3.2 Sanofi-Aventis Product Information
      • 4.3.3 Sanofi-Aventis RNA Drugs Business Performance
      • 4.3.4 Sanofi-Aventis RNA Drugs Business Development and Market Status
    • 4.4 Abbott Laboratories
      • 4.4.1 Abbott Laboratories Profiles
      • 4.4.2 Abbott Laboratories Product Information
      • 4.4.3 Abbott Laboratories RNA Drugs Business Performance
      • 4.4.4 Abbott Laboratories RNA Drugs Business Development and Market Status
    • 4.5 Arrowhead Pharmaceuticals
      • 4.5.1 Arrowhead Pharmaceuticals Profiles
      • 4.5.2 Arrowhead Pharmaceuticals Product Information
      • 4.5.3 Arrowhead Pharmaceuticals RNA Drugs Business Performance
      • 4.5.4 Arrowhead Pharmaceuticals RNA Drugs Business Development and Market Status
    • 4.6 Benitec Biopharma
      • 4.6.1 Benitec Biopharma Profiles
      • 4.6.2 Benitec Biopharma Product Information
      • 4.6.3 Benitec Biopharma RNA Drugs Business Performance
      • 4.6.4 Benitec Biopharma RNA Drugs Business Development and Market Status
    • 4.7 Calimmune Inc
      • 4.7.1 Calimmune Inc Profiles
      • 4.7.2 Calimmune Inc Product Information
      • 4.7.3 Calimmune Inc RNA Drugs Business Performance
      • 4.7.4 Calimmune Inc RNA Drugs Business Development and Market Status
    • 4.8 Dicerna
      • 4.8.1 Dicerna Profiles
      • 4.8.2 Dicerna Product Information
      • 4.8.3 Dicerna RNA Drugs Business Performance
      • 4.8.4 Dicerna RNA Drugs Business Development and Market Status
    • 4.9 Gradalis
      • 4.9.1 Gradalis Profiles
      • 4.9.2 Gradalis Product Information
      • 4.9.3 Gradalis RNA Drugs Business Performance
      • 4.9.4 Gradalis RNA Drugs Business Development and Market Status
    • 4.10 Quark
      • 4.10.1 Quark Profiles
      • 4.10.2 Quark Product Information
      • 4.10.3 Quark RNA Drugs Business Performance
      • 4.10.4 Quark RNA Drugs Business Development and Market Status
    • 4.11 RXi
    • 4.12 Senesco
    • 4.13 Sanofi-Aventis
    • 4.14 Abbott Laboratories
    • 4.15 Arrowhead Pharmaceuticals
    • 4.20 Quark

    5 Market Performance for Manufacturers

    • 5.1 Global RNA Drugs Production (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Global RNA Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Global RNA Drugs Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Global RNA Drugs Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Global RNA Drugs Market Performance (Production Point)

    • 6.1 Global RNA Drugs Production (K Units) and Market Share by Regions 2013-2018
    • 6.2 Global RNA Drugs Revenue (M USD) and Market Share by Regions 2013-2018
    • 6.3 Global RNA Drugs Price (USD/Unit) by Regions 2013-2018
    • 6.4 Global RNA Drugs Gross Margin by Regions 2013-2018

    7 Development Trend for Regions (Production Point)

    • 7.1 Global RNA Drugs Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
    • 7.2 China RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.3 USA RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.4 Europe RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.5 Japan RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.6 Korea RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.7 India RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.8 Southeast Asia RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
    • 7.9 South America RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

    8 Global RNA Drugs Market Performance (Consumption Point)

    • 8.1 Global RNA Drugs Consumption and Market Share by Regions 2013-2018
    • 8.2 Global RNA Drugs Consumption Value and Market Share by Regions 2013-2018
    • 8.3 Global RNA Drugs Price (USD/Unit) by Regions 2013-2018

    9 Development Trend for Regions (Sales Point)

    • 9.1 Global RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.2 China RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.3 USA RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.4 Europe RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.5 Japan RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.6 Korea RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.7 India RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.8 Southeast Asia RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
    • 9.9 South America RNA Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

    10 Upstream Source, Technology and Cost

    • 10.1 Upstream Source
    • 10.2 Technology
    • 10.3 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Consumer Analysis

    • 12.1 Cancer Industry
    • 12.2 Diabetes Industry
    • 12.3 Tuberculosis Industry
    • 12.4 Cardiovascular Diseases Industry

    13 Market Forecast 2019-2024

    • 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 13.1.1 Global RNA Drugs Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 13.1.2 Global RNA Drugs Production (K Units) and Growth Rate 2019-2024
      • 13.1.3 China RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.4 USA RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.5 Europe RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.6 Japan RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.7 Korea RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.8 India RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.9 Southeast Asia RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.1.10 South America RNA Drugs Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.2 Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.1 Global RNA Drugs Consumption and Market Share by Regions 2019-2024
      • 13.2.2 Global RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.3 China RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.4 USA RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.5 Europe RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.6 Japan RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.7 Korea RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.8 India RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.9 Southeast Asia RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
      • 13.2.10 South America RNA Drugs Sales, Sales Value and Growth Rate 2019-2024
    • 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
      • 13.3.1 Overall Market Performance
      • 13.3.2 siRNA Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.3 ASO Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.4 miRNA Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 13.3.5 Nucleic Acid Aptamers Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 13.4 Sales by Application 2019-2024
      • 13.4.1 Overall Market Performance
      • 13.4.2 Cancer Sales and and Growth Rate 2019-2024
      • 13.4.3 Diabetes Sales and and Growth Rate 2019-2024
      • 13.4.4 Tuberculosis Sales and and Growth Rate 2019-2024
      • 13.4.5 Cardiovascular Diseases Sales and and Growth Rate 2019-2024
    • 13.5 Price (USD/Unit) and Gross Profit
      • 13.5.1 Global RNA Drugs Price (USD/Unit) Trend 2019-2024
      • 13.5.2 Global RNA Drugs Gross Profit Trend 2019-2024

    14 Conclusion

    Geographically, global RNA Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Pfizer
    Roche
    Sanofi-Aventis
    Abbott Laboratories
    Arrowhead Pharmaceuticals
    Benitec Biopharma
    Calimmune Inc
    Dicerna
    Gradalis
    Quark
    RXi
    Senesco
    Silence Therapeutics
    Silenseed
    Tekmira

    On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
    siRNA
    ASO
    miRNA
    Nucleic Acid Aptamers
    For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of RNA Drugs for each application, including
    Cancer
    Diabetes
    Tuberculosis
    Cardiovascular Diseases
    Others
    Production, consumption, revenue, market share and growth rate are the key targets for RNA Drugs from 2013 to 2024 (forecast) in these regions
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now